TARO PHARMACEUTICALS NORTH AMERICA – Trademark Portfolio

Entity Type: 03

TARO PHARMACEUTICALS NORTH AMERICA holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include OVIDE and TOPICORT. The owner is based in George Town.

190 Elgin Avenue

George Town KY1-9005 , KY

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PRIMSOL
PRIMSOL
Cancelled 1994
OVIDE
OVIDE
Registered 1989
A/T/S
A/T/S
Cancelled 1980
TOPICORT
TOPICORT
Registered 1976
TOPICORT
TOPICORT
Cancelled 1955

Trademark Classifications

TARO PHARMACEUTICALS NORTH AMERICA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does TARO PHARMACEUTICALS NORTH AMERICA have?

TARO PHARMACEUTICALS NORTH AMERICA has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.

What trademark classes does TARO PHARMACEUTICALS NORTH AMERICA file in?

TARO PHARMACEUTICALS NORTH AMERICA files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are TARO PHARMACEUTICALS NORTH AMERICA's most well-known trademarks?

TARO PHARMACEUTICALS NORTH AMERICA's registered trademark portfolio includes well-known marks such as OVIDE and TOPICORT. These are among 2 currently registered trademarks in the portfolio.

What is TARO PHARMACEUTICALS NORTH AMERICA's trademark registration success rate?

TARO PHARMACEUTICALS NORTH AMERICA has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.